. 2014 Jun 19;9:3005–3012. doi: 10.2147/IJN.S60564
© 2014 Ueno et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
Figure 1.
The 50% inhibitory concentration (IC50) values of oxaliplatin and NC-4016.